AVEO Oncology
AVEO
#7475
Rank
A$0.75 B
Marketcap
A$21.69
Share price
0.00%
Change (1 day)
154.63%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -A$40.76 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are A$94.31 Million. In 2021 the company made an earning of -A$77.15 Million a decrease over its 2020 earnings that were of -A$51.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$40.76 Million-47.17%
2021 -A$77.15 Million49.9%
2020 -A$51.47 Million-479.04%
2019 A$13.57 M-276.17%
2018 -A$7.71 Million-91.79%
2017 -A$93.9 Million142.38%
2016 -A$38.75 Million78.51%
2015 -A$21.71 Million-71.55%
2014 -A$76.28 Million-50.72%
2013 -A$0.16 Billion-4.88%
2012 -A$0.17 Billion-426.29%
2011 A$49.87 M-159.85%
2010 -A$83.34 Million35.33%
2009 -A$61.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$50.28 B-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.87 B-35,524.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$1.46 B-3,582.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.47 B-17,889.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.38 B-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.27 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA